Attività
- biofarmaci (52,6%): sintesi esclusive, prodotti di fermentazione microbiologica, colture cellulari di mammiferi, ecc;
- capsule e soluzioni di dosaggio per biofarmaci, farmaci e prodotti nutrizionali (20,3%). Inoltre, il gruppo offre ingredienti nutrizionali;
- sostanze farmacologiche a piccole molecole (13,2%);
- tecnologie e piattaforme per i processi di fabbricazione e la produzione di terapie cellulari e geniche (11,1%);
- altro (2,8%).
Le vendite nette sono distribuite geograficamente come segue: Svizzera (16%), Europa (29,8%), Stati Uniti (38,8%), Americhe (3%), Giappone (3,7%), Cina (2,6%), Asia (5,8%) e altro (0,3%).
Vendite per attività
CHF in Milioni | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
Biologics
55,4
%
| 3 274 | 52,6 % | 3 719 | 55,4 % | +13,59% |
Capsules & Health Ingredients
17,3
%
| 1 266 | 20,3 % | 1 161 | 17,3 % | -8,29% |
Small Molecules
13,4
%
| 819 | 13,2 % | 901 | 13,4 % | +10,01% |
Cell & Gene
10,4
%
| 693 | 11,1 % | 696 | 10,4 % | +0,43% |
Corporate/Eliminations
3,6
%
| 171 | 2,7 % | 240 | 3,6 % | +40,35% |
Vendite per regione
CHF in Milioni | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
United States
31,8
%
| 2 415 | 38,8 % | 2 136 | 31,8 % | -11,55% |
Switzerland
17,4
%
| 996 | 16,0 % | 1 168 | 17,4 % | +17,27% |
Japan
8,1
%
| 227 | 3,6 % | 544 | 8,1 % | +139,65% |
Ireland
5,5
%
| 343 | 5,5 % | 368 | 5,5 % | +7,29% |
Belgium
5,1
%
| 302 | 4,9 % | 341 | 5,1 % | +12,91% |
Denmark
4,8
%
| 158 | 2,5 % | 322 | 4,8 % | +103,80% |
Germany
4,5
%
| 224 | 3,6 % | 302 | 4,5 % | +34,82% |
Rest of Europe
2,9
%
| 207 | 3,3 % | 195 | 2,9 % | -5,80% |
China
2,6
%
| 161 | 2,6 % | 172 | 2,6 % | +6,83% |
United Kingdom
2,5
%
| 139 | 2,2 % | 171 | 2,5 % | +23,02% |
Singapore
2,0
%
| 113 | 1,8 % | 137 | 2,0 % | +21,24% |
Sweden
1,8
%
| 143 | 2,3 % | 123 | 1,8 % | -13,99% |
France
1,7
%
| 116 | 1,9 % | 111 | 1,7 % | -4,31% |
South Korea
1,4
%
| 141 | 2,3 % | 97 | 1,4 % | -31,21% |
Canada
1,3
%
| 63 | 1,0 % | 90 | 1,3 % | +42,86% |
Netherlands
1,3
%
| 132 | 2,1 % | 88 | 1,3 % | -33,33% |
Brazil
1,1
%
| 49 | 0,8 % | 71 | 1,1 % | +44,90% |
Italy
0,8
%
| 41 | 0,7 % | 52 | 0,8 % | +26,83% |
India
0,6
%
| 42 | 0,7 % | 42 | 0,6 % | -.--% |
Spain
0,6
%
| 41 | 0,7 % | 40 | 0,6 % | -2,44% |
Mexico
0,5
%
| 34 | 0,5 % | 33 | 0,5 % | -2,94% |
Rest of Asia
0,4
%
| 36 | 0,6 % | 29 | 0,4 % | -19,44% |
Rest of Latin America
0,4
%
| 38 | 0,6 % | 26 | 0,4 % | -31,58% |
Australia & New Zealand
0,2
%
| 21 | 0,3 % | 16 | 0,2 % | -23,81% |
Thailand
0,2
%
| 15 | 0,2 % | 15 | 0,2 % | -.--% |
Indonesia
0,2
%
| 16 | 0,3 % | 14 | 0,2 % | -12,50% |
Czech Republic
0,2
%
| 7 | 0,1 % | 11 | 0,2 % | +57,14% |
Other Countries
0,0
%
| 2 | 0,0 % | 2 | 0,0 % | -.--% |
Rest of North and Central America
0,0
%
| 1 | 0,0 % | 1 | 0,0 % | -.--% |
Dirigenti
Dirigenti | Titolo | Età | Da |
---|---|---|---|
Albert Baehny
CEO | Chief Executive Officer | 72 | 25/04/17 |
Philippe Deecke
DFI | Director of Finance/CFO | 52 | 01/12/21 |
Maria Nunez
COO | Chief Operating Officer | 55 | 01/08/22 |
Lyle Wheeler
IRC | Investor Relations Contact | - | - |
Amministratori
Amministratori | Titolo | Età | Da |
---|---|---|---|
Barbara Richmond
BRD | Director/Board Member | 63 | 16/04/14 |
Director/Board Member | 66 | 16/04/14 | |
Marion Helmes
BRD | Director/Board Member | 58 | 05/05/22 |
Albert Baehny
CEO | Chief Executive Officer | 72 | 25/04/17 |
Christoph Mäder
BRD | Director/Board Member | 64 | 26/04/16 |
Roger Nitsch
BRD | Director/Board Member | 63 | 01/05/22 |
Director/Board Member | 64 | 04/05/18 | |
Director/Board Member | 52 | 04/05/18 |
Classe di azioni
Voto | Quantità | Flottante | Autocontrollo | Flottante totale | |
---|---|---|---|---|---|
Azione A | 1 | 74 468 752 | 71 395 423 ( 95,87 %) | 2 352 163 ( 3,159 %) | 95,87 % |
Partecipazioni
Nome | Azioni | % | Valorizzazione |
---|---|---|---|
LONZA GROUP AG 3.16% | 2 352 163 | 3.16% | 1 308 994 140 $ |
Coordinate società
Società del gruppo
Nome | Categoria e settore |
---|---|
Arch Protection Chemicals Pvt Ltd.
Arch Protection Chemicals Pvt Ltd. Miscellaneous Commercial ServicesCommercial Services Part of Lonza Group AG, Arch Protection Chemicals Pvt Ltd. is an Indian company that provides business services. The company is based in Mumbai, India. |
Miscellaneous Commercial Services
|
Arch UK Biocides Ltd.
Arch UK Biocides Ltd. Household/Personal CareConsumer Non-Durables Part of Lonza Group AG, Arch UK Biocides Ltd. is a provider of integrated healthcare solutions to the pharmaceutical, biotech, and specialty ingredients markets. The company is based in Castleford, UK, and offers careers in various disciplines such as bioengineering and chemistry. Lonza optimizes scientific innovation and manufacturing technology to enable its customers to serve their patients and consumers. Lonza's quality management is committed to meeting all specifications and fulfilling customer needs and expectations. Founded in 2003, the British company's solutions aim to improve life quality by preventing illness, enabling healthier lifestyles, and supporting a safe environment. |
Household/Personal Care
|
Capsugel Italy SRL
Capsugel Italy SRL Miscellaneous Commercial ServicesCommercial Services Part of Chester Investor Holdings SRL, Capsugel Italy SRL provides management consulting services. The company is based in Milan, Italy. |
Miscellaneous Commercial Services
|
Hickson Ltd.
Hickson Ltd. Miscellaneous Commercial ServicesCommercial Services Founded in 1937, Hickson Ltd. is a business consulting British company that provides consulting services. The company is based in Castleford, UK and is part of Lonza Group AG. |
Miscellaneous Commercial Services
|
Capsugel Hungary Kft
| |
Innovative Water Care Europe SAS
Innovative Water Care Europe SAS Specialty StoresRetail Trade Innovative Water Care Europe SAS manufactures basic organic chemicals. The company was founded on September 17, 1982 and is headquartered in Amboise, France. |
Specialty Stores
|
Capsugel France SAS
Capsugel France SAS Apparel/Footwear RetailRetail Trade Capsugel France SAS manufactures & distributes clothes and clothing accessories. The company was founded in 1970 and is headquartered in Colmar, France. |
Apparel/Footwear Retail
|
Capsugel Financeco SCA
Capsugel Financeco SCA Pharmaceuticals: MajorHealth Technology Part of Lonza Group AG, Capsugel Financeco SCA is a Luxembourger pharmaceutical company founded in 2011. The company manufactures pharmaceutical products and is based in Luxembourg, Luxembourg. |
Pharmaceuticals: Major
|
Capsugel Germany GmbH
|
Settore
Vendite per attività
Vendite per regione
Variaz. 1 gen. | Capi. | |
---|---|---|
+39,57% | 54,04 Mrd | |
-1,11% | 41,92 Mrd | |
-7,59% | 28,35 Mrd | |
+12,83% | 26,35 Mrd | |
-22,08% | 19 Mrd | |
+7,67% | 13 Mrd | |
+28,48% | 12,28 Mrd | |
+24,62% | 12,19 Mrd | |
-6,48% | 11,49 Mrd |